Hunter C Smith Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hunter C Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hunter C Smith. Hunter C Smith is Director in GENESEE & WYOMING INC ($GWR) and CFO and Interim CEO in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and CFO and Treasurer in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Chief Financial Officer in RHYTHM PHARMACEUTICALS, INC. ($RYTM).
Latest Insider Trading Transactions of Hunter C Smith
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 23 2021 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | M | 6.88 | 5,000 | 34,400 | 163,094 | |
Apr 23 2021 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Buy | M | 6.88 | 5,000 | 34,400 | 38,650 | 33.7 K to 38.7 K (+14.86 %) |
Jan 20 2021 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | M | 6.88 | 4,000 | 27,520 | 168,094 | |
Jan 20 2021 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Buy | M | 6.88 | 4,000 | 27,520 | 33,650 | 29.7 K to 33.7 K (+13.49 %) |
Jul 21 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | A | 22.53 | 25,000 | 563,250 | 25,000 | |
Mar 31 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | CFO and Interim CEO | Option Exercise | M | 6.88 | 3,900 | 26,832 | 172,094 | |
Mar 31 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | CFO and Interim CEO | Buy | M | 6.88 | 3,900 | 26,832 | 29,650 | 25.8 K to 29.7 K (+15.15 %) |
Mar 16 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | M | 6.88 | 3,500 | 24,080 | 175,994 | |
Mar 16 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Buy | M | 6.88 | 3,500 | 24,080 | 25,750 | 22.3 K to 25.8 K (+15.73 %) |
Feb 19 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | A | 17.87 | 82,000 | 1,465,340 | 82,000 | |
Jan 29 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | M | 6.88 | 6,250 | 43,000 | 179,494 | |
Jan 29 2020 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Buy | M | 6.88 | 6,250 | 43,000 | 22,250 | 16 K to 22.3 K (+39.06 %) |
Dec 30 2019 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Sell | D | 112.00 | 11,824 | 1,324,288 | 0 | 11.8 K to 0 (-100.00 %) |
Oct 02 2019 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 110.67 | 166 | 18,371 | 11,824 | 11.7 K to 11.8 K (+1.42 %) |
Jul 15 2019 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | M | 6.88 | 10,000 | 68,800 | 185,744 | |
Jul 15 2019 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Buy | M | 6.88 | 10,000 | 68,800 | 16,000 | 6 K to 16 K (+166.67 %) |
Jul 02 2019 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 98.57 | 307 | 30,261 | 11,658 | 11.4 K to 11.7 K (+2.70 %) |
May 24 2019 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 86.07 | 1,161 | 99,927 | 11,351 | 10.2 K to 11.4 K (+11.39 %) |
Apr 02 2019 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 86.88 | 291 | 25,282 | 10,190 | 9.9 K to 10.2 K (+2.94 %) |
Feb 15 2019 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | A | 29.78 | 70,000 | 2,084,600 | 70,000 | |
Feb 04 2019 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | M | 6.88 | 3,000 | 20,640 | 195,744 | |
Feb 04 2019 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Buy | M | 6.88 | 3,000 | 20,640 | 6,000 | 3 K to 6 K (+100.00 %) |
Jan 03 2019 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 73.80 | 326 | 24,059 | 9,899 | 9.6 K to 9.9 K (+3.41 %) |
Oct 02 2018 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 91.61 | 249 | 22,811 | 9,573 | 9.3 K to 9.6 K (+2.67 %) |
Sep 06 2018 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Option Exercise | M | 6.88 | 3,000 | 20,640 | 198,744 | |
Sep 06 2018 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | Chief Financial Off ... | Buy | M | 6.88 | 3,000 | 20,640 | 3,000 | 0 to 3 K |
May 25 2018 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 0.00 | 1,301 | 0 | 9,095 | 7.8 K to 9.1 K (+16.69 %) |
Feb 16 2018 | RYTM | RHYTHM PHARMACEUTI ... | Smith Hunter C | CFO and Treasurer | Option Exercise | A | 25.79 | 61,000 | 1,573,190 | 61,000 | |
Jan 03 2018 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 78.72 | 361 | 28,418 | 7,496 | 7.1 K to 7.5 K (+5.06 %) |
Oct 03 2017 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 73.53 | 250 | 18,383 | 7,135 | 6.9 K to 7.1 K (+3.63 %) |
Jul 05 2017 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 67.83 | 271 | 18,382 | 6,885 | 6.6 K to 6.9 K (+4.10 %) |
May 25 2017 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 0.00 | 1,389 | 0 | 6,614 | 5.2 K to 6.6 K (+26.58 %) |
Apr 04 2017 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 68.10 | 270 | 18,387 | 5,225 | 5 K to 5.2 K (+5.45 %) |
Jan 04 2017 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 69.59 | 354 | 24,635 | 4,955 | 4.6 K to 5 K (+7.69 %) |
Oct 04 2016 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 68.10 | 307 | 20,907 | 4,601 | 4.3 K to 4.6 K (+7.15 %) |
Jul 05 2016 | GWR | GENESEE & WYOMING ... | Smith Hunter C | Director | Grant | A | 57.23 | 365 | 20,889 | 4,294 | 3.9 K to 4.3 K (+9.29 %) |
May 19 2016 | GWR | GENESEE & WYOM ... | Smith Hunter C | Director | Grant | A | 0.00 | 1,586 | 0 | 3,929 | 2.3 K to 3.9 K (+67.69 %) |
Apr 04 2016 | GWR | GENESEE & WYOM ... | Smith Hunter C | Director | Grant | A | 63.30 | 370 | 23,421 | 2,343 | 2 K to 2.3 K (+18.75 %) |
Jan 05 2016 | GWR | GENESEE & WYOM ... | Smith Hunter C | Director | Grant | A | 54.08 | 340 | 18,387 | 1,973 | 1.6 K to 2 K (+20.82 %) |
Oct 02 2015 | GWR | GENESEE & WYOM ... | Smith Hunter C | Director | Grant | A | 57.51 | 407 | 23,407 | 1,633 | 1.2 K to 1.6 K (+33.20 %) |
Jul 02 2015 | GWR | GENESEE & WYOM ... | Smith Hunter C | Director | Grant | A | 76.62 | 216 | 16,550 | 1,226 | 1 K to 1.2 K (+21.39 %) |
May 13 2015 | GWR | GENESEE & WYOM ... | Smith Hunter C | Director | Grant | A | 0.00 | 1,003 | 0 | 1,010 | 7 to 1 K (+14,328.57 %) |
Apr 02 2015 | GWR | GENESEE & WYOM ... | Smith Hunter C | Director | Grant | A | 97.19 | 7 | 680 | 7 | 0 to 7 |
Page: 1